| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2025 ( Subtotal = $0 ) |
| | 2025 | 2023 | SIGRAY, INC. | 5500 E 2ND ST | BENICIA | CA | 94510-1020 | SOLANO | USA | R42GM142394 | Development of a Bio-tissue Oxygenation Nanophosphor Enabled Sensing (BONES) system for Quantifying Hypoxia in Bone Marrow | 000 | 3 | NIH | 7/1/2025 | $0 |
| | 2025 | 2023 | SIGRAY, INC. | 5750 IMHOFF DR | CONCORD | CA | 94520-5345 | CONTRA COSTA | USA | R44GM148148 | Cryogenic High-throughput Cellular Imaging System | 000 | 2 | NIH | 1/23/2025 | $0 |
|
| Issue Date FY: 2024 ( Subtotal = $0 ) |
| | 2024 | 2022 | SIGRAY, INC. | 5750 IMHOFF DR | CONCORD | CA | 94520-5345 | CONTRA COSTA | USA | R44HL154950 | Development of a low dose clinical lung screening prototype for early detection of COPD and lung cancer using a novel x-ray source to enable Talbot-Lau interferometry | 000 | 3 | NIH | 1/19/2024 | $0 |
|
| Issue Date FY: 2023 ( Subtotal = $1,529,205 ) |
| | 2023 | 2023 | SIGRAY, INC. | 5750 IMHOFF DR STE I | CONCORD | CA | 94520-5348 | CONTRA COSTA | USA | R42GM142394 | Development of a Bio-tissue Oxygenation Nanophosphor Enabled Sensing (BONES) system for Quantifying Hypoxia in Bone Marrow | 000 | 3 | NIH | 2/22/2023 | $796,697 |
| | 2023 | 2023 | SIGRAY, INC. | 5750 IMHOFF DR | CONCORD | CA | 94520-5345 | CONTRA COSTA | USA | R44GM148148 | Cryogenic High-throughput Cellular Imaging System | 000 | 2 | NIH | 9/20/2023 | $732,508 |
| | 2023 | 2022 | SIGRAY, INC. | 5750 IMHOFF DR | CONCORD | CA | 94520-5345 | CONTRA COSTA | USA | R44GM137743 | Development of a Quantitative Iron Characterization System for Alzheimer's Disease Using Computed Laminography X-ray Fluorescence Imaging (CL-XRFI) | 000 | 3 | NIH | 7/28/2023 | $0 |
| | 2023 | 2021 | SIGRAY, INC. | 5750 IMHOFF DR | CONCORD | CA | 94520-5345 | CONTRA COSTA | USA | R44GM137675 | Development of a Laboratory Transmission X-ray Microscope for Rapid 3D Cellular Tomography using Zernike Phase Contrast with 2.7 keV | 000 | 3 | NIH | 9/28/2023 | $0 |
|
| Issue Date FY: 2022 ( Subtotal = $3,475,344 ) |
| | 2022 | 2022 | SIGRAY, INC. | 5750 IMHOFF DR STE I | CONCORD | CA | 94520-5348 | CONTRA COSTA | USA | R42GM142394 | Development of a Bio-tissue Oxygenation Nanophosphor Enabled Sensing (BONES) system for Quantifying Hypoxia in Bone Marrow | 002 | 2 | NIH | 4/13/2022 | $63,615 |
| | 2022 | 2022 | SIGRAY, INC. | 5750 IMHOFF DR STE I | CONCORD | CA | 94520-5348 | CONTRA COSTA | USA | R44GM137743 | Development of a Quantitative Iron Characterization System for Alzheimer's Disease Using Computed Laminography X-ray Fluorescence Imaging (CL-XRFI) | 000 | 3 | NIH | 11/30/2021 | $795,227 |
| | 2022 | 2022 | SIGRAY, INC. | 5750 IMHOFF DR STE I | CONCORD | CA | 94520-5348 | CONTRA COSTA | USA | R44GM148148 | Cryogenic High-throughput Cellular Imaging System | 000 | 1 | NIH | 9/9/2022 | $998,003 |
| | 2022 | 2022 | SIGRAY, INC. | 5750 IMHOFF DR STE I | CONCORD | CA | 94520-5348 | CONTRA COSTA | USA | R42GM142394 | Development of a Bio-tissue Oxygenation Nanophosphor Enabled Sensing (BONES) system for Quantifying Hypoxia in Bone Marrow | 000 | 2 | NIH | 2/15/2022 | $866,510 |
| | 2022 | 2022 | SIGRAY, INC. | 5750 IMHOFF DR STE I | CONCORD | CA | 94520-5348 | CONTRA COSTA | USA | R44HL154950 | Development of a low dose clinical lung screening prototype for early detection of COPD and lung cancer using a novel x-ray source to enable Talbot-Lau interferometry | 000 | 3 | NIH | 6/15/2022 | $815,604 |
| | 2022 | 2021 | SIGRAY, INC. | 5750 IMHOFF DR STE I | CONCORD | CA | 94520-5348 | CONTRA COSTA | USA | R42GM142394 | Development of a Bio-tissue Oxygenation Nanophosphor Enabled Sensing (BONES) system for Quantifying Hypoxia in Bone Marrow | 001 | 1 | NIH | 4/13/2022 | -$63,615 |
| | 2022 | 2020 | SIGRAY, INC. | 5750 IMHOFF DR STE I | CONCORD | CA | 94520-5348 | CONTRA COSTA | USA | R44GM133287 | A sub-cellular micro x-ray fluorescence system for elemental imaging at fast acquisition times in biological tissue | 000 | 3 | NIH | 4/18/2022 | $0 |
|
| Issue Date FY: 2021 ( Subtotal = $2,723,741 ) |
| | 2021 | 2021 | SIGRAY, INC. | 5750 IMHOFF DR STE I | CONCORD | CA | 94520-5348 | CONTRA COSTA | USA | R42GM142394 | Development of a Bio-tissue Oxygenation Nanophosphor Enabled Sensing (BONES) system for Quantifying Hypoxia in Bone Marrow | 000 | 1 | NIH | 5/17/2021 | $252,113 |
| | 2021 | 2021 | SIGRAY, INC. | 5750 IMHOFF DR STE I | CONCORD | CA | 94520-5348 | CONTRA COSTA | USA | R44GM137743 | Development of a Quantitative Iron Characterization System for Alzheimer's Disease Using Computed Laminography X-ray Fluorescence Imaging (CL-XRFI) | 000 | 2 | NIH | 11/20/2020 | $844,695 |
| | 2021 | 2021 | SIGRAY, INC. | 5750 IMHOFF DR STE I | CONCORD | CA | 94520-5348 | CONTRA COSTA | USA | R44GM137675 | Development of a Laboratory Transmission X-ray Microscope for Rapid 3D Cellular Tomography using Zernike Phase Contrast with 2.7 keV | 000 | 3 | NIH | 6/14/2021 | $786,248 |
| | 2021 | 2021 | SIGRAY, INC. | 5750 IMHOFF DR STE I | CONCORD | CA | 94520-5348 | CONTRA COSTA | USA | R44HL154950 | Development of a low dose clinical lung screening prototype for early detection of COPD and lung cancer using a novel x-ray source to enable Talbot-Lau interferometry | 000 | 2 | NIH | 5/31/2021 | $840,685 |
| | 2021 | 2020 | SIGRAY, INC. | 5750 IMHOFF DR STE I | CONCORD | CA | 94520-5348 | CONTRA COSTA | USA | R44HL154950 | Development of a low dose clinical lung screening prototype for early detection of COPD and lung cancer using a novel x-ray source to enable Talbot-Lau interferometry | 001 | 1 | NIH | 6/30/2021 | $0 |
| | 2021 | 2020 | SIGRAY, INC. | 5750 IMHOFF DR STE I | CONCORD | CA | 94520-5348 | CONTRA COSTA | USA | R44CA228912 | Development of a laboratory XANES system for the analysis of metals in tissue for cancer research and chemotherapy drug development | 000 | 3 | NIH | 4/22/2021 | $0 |
|
| Issue Date FY: 2020 ( Subtotal = $2,574,683 ) |
| | 2020 | 2020 | SIGRAY, INC. | 5750 IMHOFF DR STE I | CONCORD | CA | 94520-5348 | CONTRA COSTA | USA | R44GM133287 | A sub-cellular micro x-ray fluorescence system for elemental imaging at fast acquisition times in biological tissue | 001 | 3 | NIH | 8/21/2020 | $632,182 |
| | 2020 | 2020 | SIGRAY, INC. | 5750 IMHOFF DR STE I | CONCORD | CA | 94520-5348 | CONTRA COSTA | USA | R44GM137675 | Development of a Laboratory Transmission X-ray Microscope for Rapid 3D Cellular Tomography using Zernike Phase Contrast with 2.7 keV | 000 | 2 | NIH | 4/13/2020 | $857,728 |
| | 2020 | 2020 | SIGRAY, INC. | 5750 IMHOFF DR STE I | CONCORD | CA | 94520-5348 | CONTRA COSTA | USA | R44HL154950 | Development of a low dose clinical lung screening prototype for early detection of COPD and lung cancer using a novel x-ray source to enable Talbot-Lau interferometry | 000 | 1 | NIH | 8/24/2020 | $246,220 |
| | 2020 | 2020 | SIGRAY, INC. | 5750 IMHOFF DR STE I | CONCORD | CA | 94520-5348 | CONTRA COSTA | USA | R44GM137743 | Development of a Quantitative Iron Characterization System for Alzheimer's Disease Using Computed Laminography X-ray Fluorescence Imaging (CL-XRFI) | 000 | 1 | NIH | 4/7/2020 | $247,818 |
| | 2020 | 2020 | SIGRAY, INC. | 5750 IMHOFF DR STE I | CONCORD | CA | 94520-5348 | CONTRA COSTA | USA | R44CA228912 | Development of a laboratory XANES system for the analysis of metals in tissue for cancer research and chemotherapy drug development | 000 | 3 | NIH | 12/23/2019 | $590,735 |
| | 2020 | 2019 | SIGRAY, INC. | 5750 IMHOFF DR STE I | CONCORD | CA | 94520-5348 | CONTRA COSTA | USA | R44GM133287 | A sub-cellular micro x-ray fluorescence system for elemental imaging at fast acquisition times in biological tissue | 000 | 1 | NIH | 2/23/2020 | $0 |
| | 2020 | 2018 | SIGRAY, INC. | 5750 IMHOFF DR STE I | CONCORD | CA | 94520-5348 | CONTRA COSTA | USA | R44EB023284 | A high brightness microstructured anode X-ray source for clinical phase contrast imaging | 000 | 3 | NIH | 11/23/2019 | $0 |
| | 2020 | 2017 | SIGRAY, INC. | 5750 IMHOFF DR STE I | CONCORD | CA | 94520-5348 | CONTRA COSTA | USA | R44GM112287 | High throughput laboratory X-ray illumination system for protein crystallography and screening | 000 | 3 | NIH | 11/16/2019 | $0 |
|
| Issue Date FY: 2019 ( Subtotal = $1,960,960 ) |
| | 2019 | 2019 | SIGRAY, INC. | 5750 IMHOFF DR STE I | CONCORD | CA | 94520-5348 | CONTRA COSTA | USA | R44GM133287 | A sub-cellular micro x-ray fluorescence system for elemental imaging at fast acquisition times in biological tissue | 000 | 1 | NIH | 3/26/2019 | $224,997 |
| | 2019 | 2019 | SIGRAY, INC. | 5750 IMHOFF DR STE I | CONCORD | CA | 94520-5348 | CONTRA COSTA | USA | R44GM133287 | A sub-cellular micro x-ray fluorescence system for elemental imaging at fast acquisition times in biological tissue | 001 | 1 | NIH | 9/16/2019 | $0 |
| | 2019 | 2019 | SIGRAY, INC. | 5750 IMHOFF DR STE I | CONCORD | CA | 94520-5348 | CONTRA COSTA | USA | R44GM133287 | A sub-cellular micro x-ray fluorescence system for elemental imaging at fast acquisition times in biological tissue | 002 | 2 | NIH | 9/17/2019 | $860,627 |
| | 2019 | 2019 | SIGRAY, INC. | 5750 IMHOFF DR STE I | CONCORD | CA | 94520-5348 | CONTRA COSTA | USA | R44CA228912 | Development of a laboratory XANES system for the analysis of metals in tissue for cancer research and chemotherapy drug development | 001 | 2 | NIH | 12/31/2018 | $875,336 |
| | 2019 | 2018 | SIGRAY, INC. | 5750 IMHOFF DR STE I | CONCORD | CA | 94520-5348 | CONTRA COSTA | USA | R44CA228912 | Development of a laboratory XANES system for the analysis of metals in tissue for cancer research and chemotherapy drug development | 000 | 1 | NIH | 12/11/2018 | $0 |
| | 2019 | 2017 | SIGRAY, INC. | 5750 IMHOFF DR STE I | CONCORD | CA | 94520-5348 | CONTRA COSTA | USA | R44GM112413 | A high throughput, high resolution, and high sensitivity scanning X-ray fluorescence microprobe for elemental mapping in cell cultures and tissues for medical research and diagnosis | 000 | 3 | NIH | 11/20/2018 | $0 |
| | 2019 | 2017 | SIGRAY, INC. | 5750 IMHOFF DR STE I | CONCORD | CA | 94520-5348 | CONTRA COSTA | USA | R44EB021125 | A high resolution and high DQE detector optimized for mammography using single-shot bi-directional tri-contrast imaging | 000 | 3 | NIH | 8/13/2019 | $0 |
|
| Issue Date FY: 2018 ( Subtotal = $781,673 ) |
| | 2018 | 2018 | SIGRAY, INC. | 5750 IMHOFF DR STE I | CONCORD | CA | 94520-5348 | CONTRA COSTA | USA | R44EB023284 | A high brightness microstructured anode X-ray source for clinical phase contrast imaging | 000 | 3 | NIH | 9/1/2018 | $556,848 |
| | 2018 | 2018 | SIGRAY, INC. | 5750 IMHOFF DR STE I | CONCORD | CA | 94520-5348 | CONTRA COSTA | USA | R44CA228912 | Development of a laboratory XANES system for the analysis of metals in tissue for cancer research and chemotherapy drug development | 000 | 1 | NIH | 4/4/2018 | $224,989 |
| | 2018 | 2015 | SIGRAY, INC. | 5750 IMHOFF DR STE I | CONCORD | CA | 94520-5348 | CONTRA COSTA | USA | R44EB021125 | A high resolution and high DQE detector optimized for mammography using single-shot bi-directional tri-contrast imaging | 000 | 1 | NIH | 9/17/2018 | -$145 |
| | 2018 | 2015 | SIGRAY, INC. | 5750 IMHOFF DR STE I | CONCORD | CA | 94520-5348 | CONTRA COSTA | USA | R44EB021125 | A high resolution and high DQE detector optimized for mammography using single-shot bi-directional tri-contrast imaging | 001 | 1 | NIH | 9/17/2018 | -$19 |
|
| Issue Date FY: 2017 ( Subtotal = $3,073,932 ) (Continued on the next page) |
| | 2017 | 2017 | SIGRAY, INC. | 5750 IMHOFF DR STE I | CONCORD | CA | 94520-5348 | CONTRA COSTA | USA | R44EB023284 | A high brightness microstructured anode X-ray source for clinical phase contrast imaging | 001 | 2 | NIH | 9/26/2017 | $942,194 |
| | 2017 | 2017 | SIGRAY, INC. | 5750 IMHOFF DR STE I | CONCORD | CA | 94520-5348 | CONTRA COSTA | USA | R44GM112413 | A high throughput, high resolution, and high sensitivity scanning X-ray fluorescence microprobe for elemental mapping in cell cultures and tissues for medical research and diagnosis | 000 | 3 | NIH | 6/20/2017 | $740,687 |
|
